268 related articles for article (PubMed ID: 31452444)
1. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
[TBL] [Abstract][Full Text] [Related]
2. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
3. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats.
Herr KA; Baker LE
Behav Pharmacol; 2020 Dec; 31(8):776-786. PubMed ID: 32960851
[TBL] [Abstract][Full Text] [Related]
5. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
6. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Marona-Lewicka D; Thisted RA; Nichols DE
Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
[TBL] [Abstract][Full Text] [Related]
7. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
8. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
Cunningham KA; Appel JB
Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
[TBL] [Abstract][Full Text] [Related]
9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
[TBL] [Abstract][Full Text] [Related]
10. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.
Appel JB; White FJ; Holohean AM
Neurosci Biobehav Rev; 1982; 6(4):529-36. PubMed ID: 7177512
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
12. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
Nielsen EB
J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
[TBL] [Abstract][Full Text] [Related]
14. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
15. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
Nichols CD; Garcia EE; Sanders-Bush E
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
[TBL] [Abstract][Full Text] [Related]
17. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
Winter JC; Eckler JR; Rabin RA
Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
